212 related articles for article (PubMed ID: 31052360)
1. A Functional Wound Dressing as a Potential Treatment for Cutaneous Leishmaniasis.
Alexandrino-Junior F; Silva KGHE; Freire MCLC; Lione VOF; Cardoso EA; Marcelino HR; Genre J; Oliveira AG; Egito ESTD
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052360
[TBL] [Abstract][Full Text] [Related]
2. A Novel Amphotericin B Hydrogel Composed of Poly(Vinyl Alcohol)/Borate Complex for Ophthalmic Formulation.
Banshoya K; Shirakawa M; Hieda Y; Ohnishi M; Sato Y; Inoue A; Tanaka T; Kaneo Y
Chem Pharm Bull (Tokyo); 2023; 71(1):70-73. PubMed ID: 36596514
[TBL] [Abstract][Full Text] [Related]
3. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions.
Carvalheiro M; Vieira J; Faria-Silva C; Marto J; Simões S
Drug Deliv Transl Res; 2021 Apr; 11(2):717-728. PubMed ID: 33534106
[TBL] [Abstract][Full Text] [Related]
5. Development, characterization, and anti-leishmanial activity of topical amphotericin B nanoemulsions.
Dos Santos Matos AP; Lopes DCDXP; Peixoto MLH; da Silva Cardoso V; Vermelho AB; Santos-Oliveira R; Viçosa AL; Holandino C; Ricci-Júnior E
Drug Deliv Transl Res; 2020 Dec; 10(6):1552-1570. PubMed ID: 32676952
[TBL] [Abstract][Full Text] [Related]
6. The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
Gürbüz Çolak N; Çetin Uyanikgil EÖ; Özbel Y; Töz S
Acta Parasitol; 2022 Sep; 67(3):1354-1363. PubMed ID: 35857275
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
8. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.
Dar MJ; Khalid S; McElroy CA; Satoskar AR; Khan GM
Int J Pharm; 2020 Jan; 573():118900. PubMed ID: 31765786
[TBL] [Abstract][Full Text] [Related]
9. Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.
Jaafari MR; Hatamipour M; Alavizadeh SH; Abbasi A; Saberi Z; Rafati S; Taslimi Y; Mohammadi AM; Khamesipour A
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():156-165. PubMed ID: 31582344
[TBL] [Abstract][Full Text] [Related]
10. Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.
Ramos GS; Vallejos VMR; Borges GSM; Almeida RM; Alves IM; Aguiar MMG; Fernandes C; Guimarães PPG; Fujiwara RT; Loiseau PM; Ferreira LAM; Frézard F
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631575
[TBL] [Abstract][Full Text] [Related]
11. Effective wound dressing based on Poly (vinyl alcohol)/Dextran-aldehyde composite hydrogel.
Zheng C; Liu C; Chen H; Wang N; Liu X; Sun G; Qiao W
Int J Biol Macromol; 2019 Jul; 132():1098-1105. PubMed ID: 30974136
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of
Anjum A; Shabbir K; Din FU; Shafique S; Zaidi SS; Almari AH; Alqahtani T; Maryiam A; Moneeb Khan M; Al Fatease A; Bashir S; Khan GM
Drug Deliv; 2023 Dec; 30(1):2173335. PubMed ID: 36722301
[TBL] [Abstract][Full Text] [Related]
13. Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity.
Berenguer D; Alcover MM; Sessa M; Halbaut L; Guillén C; Boix-Montañés A; Fisa R; Calpena-Campmany AC; Riera C; Sosa L
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32059430
[TBL] [Abstract][Full Text] [Related]
14. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
15. Design and performance of sericin/poly(vinyl alcohol) hydrogel as a drug delivery carrier for potential wound dressing application.
Tao G; Wang Y; Cai R; Chang H; Song K; Zuo H; Zhao P; Xia Q; He H
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():341-351. PubMed ID: 31029327
[TBL] [Abstract][Full Text] [Related]
16. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of amphotericin B-loaded electrospun core-shell nanofibers as a novel dressing for superficial mycoses and cutaneous leishmaniasis.
Asgari Q; Alishahi M; Davani F; Caravan D; Khorram M; Enjavi Y; Barzegar S; Esfandiari F; Zomorodian K
Int J Pharm; 2021 Sep; 606():120911. PubMed ID: 34298105
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.
Zahid F; Batool S; Ud-Din F; Ali Z; Nabi M; Khan S; Salman O; Khan GM
AAPS PharmSciTech; 2022 Aug; 23(6):226. PubMed ID: 35970966
[TBL] [Abstract][Full Text] [Related]
19. Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice.
de Carvalho RF; Ribeiro IF; Miranda-Vilela AL; de Souza Filho J; Martins OP; Cintra e Silva Dde O; Tedesco AC; Lacava ZG; Báo SN; Sampaio RN
Exp Parasitol; 2013 Oct; 135(2):217-22. PubMed ID: 23891944
[TBL] [Abstract][Full Text] [Related]
20. Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles.
Sousa-Batista AJ; Pacienza-Lima W; Ré MI; Rossi-Bergmann B
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():148-155. PubMed ID: 31331828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
